Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.25 - ATP:protein phosphotransferase (MAPKKKK- activated) (mitogen- activated protein kinase kinase kinase)



3D structures of EC 2.7.11.25 - mitogen-activated protein kinase kinase kinase in Protein Data Bank

updated: 6 January 2022, 2:15

In total: 87 PDB structures of EC 2.7.11.25 - mitogen-activated protein kinase kinase kinase:
  1. 3dtc: Crystal Structure of Mixed-lineage Kinase Mlk1 Complexed with Compound 16
  2. 2rf0: Crystal Structure of Human Mixed Lineage Kinase MAP3K10 Sh3 Domain
  3. 2clq: Structure of Mitogen-activated Protein Kinase Kinase Kinase 5
  4. 2pph: Solution Structure of Human Mekk3 Pb1 Domain
  5. 6xih: Structure-guided Optimization of a Novel Class of Ask1 Inhibitors with Increased Sp3 Character and an Exquisite Selectivity Profile
  6. 2o2v: Crystal Structure of The Complex of Human Mitogen Activated Protein Kinase Kinase 5 Phox Domain (MAP2K5-PHOX) with Human Mitogen Activated Protein Kinase Kinase Kinase 3 (MAP3K3B-PHOX)
  7. 6aqb: Structure of The Sh3 Domain of Mlk3 Bound to Peptide Generated from Phage Display
  8. 2npt: Crystal Structure of The Complex of Human Mitogen Activated Protein Kinase Kinase 5 Phox Domain (MAP2K5-PHOX) with Human Mitogen Activated Protein Kinase Kinase Kinase 2 Phox Domain (MAP3K2-PHOX)
  9. 6wpp: Human Nik in Complex with Ligand Compound X
  10. 2jrh: Solution Sturcture of Human Mekk3 Pb1 Domain Cis Isomer
  11. 6whb: Mekk1 Tog Domain (548-867)
  12. 6vre: Structure of Ask1 Bound to Bio-1772961
  13. 6juu: Crystal Structure of Zak in Complex with Compound 6r
  14. 6v0m: Sterile Alpha-motif from Apoptosis Signal-regulating Kinase 3
  15. 6oyw: Ask1 Kinase Domain in Complex with Compound 11
  16. 6oyt: Ask1 Kinase Domain in Complex with Gs-4997
  17. 2yiy: Crystal Structure of Compound 8 Bound to Tak1-tab
  18. 6myn: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) Bound to Inhibitor R7
  19. 4dn5: Crystal Structure of Nf-kb-inducing Kinase (nik)
  20. 4g3c: Crystal Structure of Apo Murine Nf-kappab Inducing Kinase (nik)
  21. 4g3f: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) Bound to a 2-(aminothiazoly)phenol (cmp2)
  22. 4g3g: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) V408L Bound to a 2-(aminothiazolyl)phenol (cmp3)
  23. 4g3d: Crystal Structure of Human Nf-kappab Inducing Kinase (nik)
  24. 4g3e: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) Bound to a 6-alkynylindoline (cmp1)
  25. 6jut: Crystal Structure of Zak in Complex with Compound 6k
  26. 3vw6: Crystal Structure of Human Apoptosis Signal-regulating Kinase 1 (ask1) with Imidazopyridine Inhibitor
  27. 4gs6: Irreversible Inhibition of Tak1 Kinase by 5z-7-oxozeaenol
  28. 4idt: Crystal Structure of Nik with 11-bromo-5,6,7,8-tetrahydropyrimido[4', 5':3,4]cyclohepta[1,2-b]indol-2-amine (t28)
  29. 4idv: Crystal Structure of Nik with Compound 4-{3-[2-amino-5-(2- Methoxyethoxy)pyrimidin-4-yl]-1h-indol-5-yl}-2-methylbut-3-yn-2-ol (13v)
  30. 6g4z: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) in Complex with Compound 2f
  31. 6g4y: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) in Complex with Compound 1a
  32. 4l3p: Crystal Structure of 2-(1-benzothiophen-7-yl)-4-[1-(piperidin-4-yl)- 1h-pyrazol-4-yl]furo[2,3-c]pyridin-7-amine Bound to Tak1-tab1
  33. 4bhn: Crystal Structures of Ask1-inhibitor Complexes
  34. 4bib: Crystal Structures of Ask1-inhibitor Complexes
  35. 4bic: Crystal Structures of Ask1-inhibitor Complexes
  36. 4bid: Crystal Structures of Ask1-inhibitor Complexes
  37. 4bie: Crystal Structures of Ask1-inhibitor Complexes
  38. 4l52: Crystal Structure of 1-(4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7-yl) Furo[2,3-c]pyridin-4-yl]-1h-pyrazol-1-yl}piperidin-1-yl)ethan-1-one Bound to Tak1-tab1
  39. 4l53: Crystal Structure of (1r,4r)-4-{4-[7-amino-2-(1,2,3-benzothiadiazol-7- Yl)-3-chlorofuro[2,3-c]pyridin-4-yl]-1h-pyrazol-1-yl}cyclohexan-1-ol Bound to Tak1-tab1
  40. 6ejl: Structure of 14-3-3 Zeta in Complex with Ask1 14-3-3 Binding Motif
  41. 6e2o: Ask1 Kinase Domain Complex with Inhibitor
  42. 6e2n: Ask1 Kinase Domain Complex with Inhibitor
  43. 6e2m: Ask1 Kinase Domain Complex with Inhibitor
  44. 6cq7: The Sh3 Domain of Mlk3 in Complex with Poly-proline Peptide Derived from Htt
  45. 4o91: Crystal Structure of Type II Inhibitor Ng25 Bound to Tak1-tab1
  46. 5x5o: Crystal Structure of Zak in Complex with Compound D2829
  47. 5vo2: Dlk in Complex with Inhibitor 5-(1-isopropyl-5-(1-(oxetan-3-yl) Piperidin-4-yl)-1h-pyrazol-3-yl)-3-(trifluoromethyl)pyridin-2-amine (compound 7)
  48. 5vo1: Dlk in Complex with Compound 10 (5-(1-isopropyl-5-(3-(oxetan-3-yl)-3- Azabicyclo[3.1.0]hexan-6-yl)-1h-pyrazol-3-yl)-3-(trifluoromethyl) Pyridin-2-amine)
  49. 5vio: Crystal Structure of Ask1 Kinase Domain with a Potent Inhibitor (analog 13)
  50. 5vil: Crystal Structure of Ask1 Kinase Domain with a Potent Inhibitor (analog 6)
  51. 5v5n: Crystal Structure of Takinib Bound to Tak1
  52. 5v24: Structure-based Drug Design of Novel Ask1 Inhibitors Using a Fully Integrated Lead Optimization Strategy
  53. 5v19: Structure-based Drug Design of Novel Ask1 Inhibitors Using a Fully Integrated Lead Optimization Strategy
  54. 5up3: Structure-based Design of Ask1 Inhibitors as Potential First-in-class Agents for Heart Failure
  55. 5uox: Structure-based Design of Ask1 Inhibitors as Potential First-in-class Agents for Heart Failure
  56. 5uor: Structure-based Design of Ask1 Inhibitors as Potential First-in-class Agents for Heart Failure
  57. 5ulm: Structure of The Ask1 Central Regulatory Region
  58. 5t8q: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) Bound to Aryl Pyrrole Fragment 17
  59. 5t8p: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) Bound to Benzoxepin Compound 2
  60. 5t8o: Crystal Structure of Murine Nf-kappab Inducing Kinase (nik) Bound to Imidazobenzoxepin Compound 3
  61. 5k28: Structure of The Unbound Sh3 Domain of Mlk3
  62. 5k26: Structure of The Sh3 Domain of Mlk3 Bound to Peptide Generated from Phage Display
  63. 5jk3: Crystal Structure of Tl11-128 Bound to Tak1-tab1
  64. 5jh6: Crystal Structure of Tl10-92 Bound to Tak1-tab1
  65. 5jgd: Crystal Structure of Human Tak1/tab1 Fusion Protein in Complex with Ligand 12
  66. 5jgb: Crystal Structure of Human Tak1/tab1 Fusion Protein in Complex with Ligand 10
  67. 5jga: Crystal Structure of Human Tak1/tab1 Fusion Protein in Complex with Ligand 11c
  68. 5j9l: Crystal Structure of Cpt1691 Bound to Tak1-tab1
  69. 5j8i: Crystal Structure of Tl11-113 Bound to Tak1-tab1
  70. 5j7s: Crystal Structure of Sm1-71 Bound to Tak1-tab1
  71. 5iu2: Discovery of Imidazoquinolines as a Novel Class of Potent, Selective and in Vivo Efficacious Cot Kinase Inhibitors
  72. 5hes: Human Leucine Zipper- and Sterile Alpha Motif-containing Kinase (zak, Mlt, Hccs-4, Mrk, Azk, Mltk) in Complex with Vemurafenib
  73. 5gjg: Crystal Structure of Human Tak1/tab1 Fusion Protein in Complex with Ligand 4
  74. 5gjf: Crystal Structure of Human Tak1/tab1 Fusion Protein in Complex with Ligand 3
  75. 5gjd: Crystal Structure of Human Tak1/tab1 Fusion Protein in Complex with Ligand 2
  76. 5e7r: Crystal Structure of Tl10-81 Bound to Tak1-tab1
  77. 5ceq: Dlk in Complex with Inhibitor 2-((1-cyclopentyl-5-(1-(oxetan-3-yl) Piperidin-4-yl)-1h-pyrazol-3-yl)amino)isonicotinonitrile
  78. 5cep: Dlk in Complex with Inhibitor N-(1-isopropyl-5-(piperidin-4-yl)-1h- Pyrazol-3-yl)-4-(trifluoromethyl)pyridin-2-amine
  79. 5ceo: Dlk in Complex with Inhibitor 2-((6-(3,3-difluoropyrrolidin-1-yl)-4- (1-(oxetan-3-yl)piperidin-4-yl)pyridin-2-yl)amino)isonicotinonitrile
  80. 5cen: Crystal Structure of Dlk (kinase Domain)
  81. 4y83: Crystal Structure of Cot Kinase Domain in Complex with 5-(2-amino-5- (quinolin-3-yl)pyridin-3-yl)-1,3,4-oxadiazole-2(3h)-thione
  82. 4y85: Crystal Structure of Cot Kinase Domain in Complex with 5-(5-(1h-indol- 3-yl)-1h-pyrrolo[2,3-b]pyridin-3-yl)-1,3,4-oxadiazol-2-amine
  83. 4uy9: Structure of Mlk1 Kinase Domain with Leucine Zipper 1
  84. 4uya: Structure of Mlk4 Kinase Domain with Atpgammas
  85. 4y5o: Ccm2 Hhd in Complex with Mekk3 Npb1
  86. 7nth: Structure of Tak1 in Complex with Compound 54
  87. 7nti: Structure of Tak1 in Complex with Compound 22
© Copyright 2008-2009 by enzymes.me.uk